background
human
coronaviru
new
group
coronaviru
first
character
adult
pneumonia
hong
kong
china
best
knowledg
report
date
detect
new
viru
report
molecular
method
allow
detect
also
report
clinic
present
infect
patient
method
screen
specimen
nasal
sampl
stool
sampl
receiv
februari
march
laboratori
obtain
hospit
patient
year
old
year
old
result
detect
nasal
specimen
stool
sampl
posit
sampl
obtain
patient
children
adult
clinic
present
patient
follow
admit
hospit
acut
enter
diseas
result
sever
dehydr
associ
upper
respiratori
symptom
fever
otiti
febril
seizur
sampl
obtain
investig
failur
thrive
sampl
obtain
explor
xlink
agammaglobulinemia
hyperleucocytosi
conclus
detect
respiratori
stool
sampl
children
adult
part
world
hong
kong
result
suggest
could
associ
respiratori
enter
diseas
detect
relat
persist
asymptomat
infect
patient
poor
underli
condit
detect
rtpcr
pol
gene
coronavirus
use
conserv
primer
nasopharyng
aspir
patient
complet
genom
sequenc
gener
organ
concur
coronavirus
contain
gene
character
group
coronavirus
intrigu
featur
consist
variabl
number
tandem
copi
repeat
region
code
highli
acid
domain
atr
region
despit
high
number
cell
cultur
inocul
respiratori
sampl
could
recov
cell
cultur
cytopath
effect
observ
rtpcr
perform
cultur
supernat
cell
lysat
show
lack
viral
replic
isol
hcov
cell
cultur
difficult
hcov
prototyp
strain
replic
cell
cell
cell
respect
still
primari
isol
woo
et
al
report
sarscov
recov
patient
infect
sarscov
report
date
concern
detect
laboratori
conduct
preliminari
studi
respiratori
sampl
know
new
coronaviru
detect
part
world
hong
kong
purpos
articl
present
method
use
detect
report
clinic
present
associ
infect
screen
arbitrarili
cell
cultur
show
extens
lysi
day
onset
infect
cell
inocul
respiratori
sampl
collect
patient
hospit
februari
march
univers
hospit
caen
caen
franc
age
distribut
test
patient
follow
patient
year
age
patient
year
age
patient
year
age
test
respiratori
specimen
obtain
patient
respiratori
symptom
sent
laboratori
viral
diagnosi
patient
case
minor
parent
legal
guardian
patient
consent
sampl
test
respiratori
virus
includ
coronavirus
sampl
process
routin
immunofluoresc
direct
antigen
assay
use
monoclon
antibodi
influenza
b
virus
respiratori
syncyti
viru
parainfluenzaviru
type
adenoviru
imagen
sampl
neg
result
part
strategi
inocul
sampl
neg
result
onto
cell
cultur
system
cell
line
protocol
cell
grown
medium
glutamin
fetal
calf
serum
gibco
invitrogen
penicillin
uml
gentamycin
mgml
distribut
tissu
cultur
micropl
cell
confluent
growth
medium
discard
well
inocul
ml
clinic
sampl
micropl
centrifug
rpm
min
sampl
remov
well
fill
ml
cultur
medium
supplement
fetal
calf
serum
gibco
invitrogen
day
onset
infect
cell
examin
cytopath
effect
supernat
use
amplif
techniqu
cytopath
effect
characterist
follow
small
cell
refring
cell
scatter
cultur
progress
lysi
cell
sheet
rna
extract
use
high
pure
rna
isol
kit
roch
test
rtpcr
techniqu
previous
describ
use
detect
rhinoviru
enteroviru
influenza
viru
c
rtpcr
amplif
fragment
perform
use
onestep
rtpcr
kit
qiagen
follow
primer
set
defin
n
gene
genbank
sequenc
databas
access
number
sen
antisens
reaction
undertaken
use
onestep
rtpcr
kit
qiagen
courtaboeuf
accord
manufactur
protocol
rtpcr
test
perform
use
usual
precaut
avoid
contamin
crossreact
rtpcr
assay
observ
classic
hcov
assay
perform
without
posit
control
rtpcr
product
process
agaros
gel
stain
ethidium
bromid
visual
uv
light
posit
result
confirm
sequenc
amplifi
product
rtpcr
perform
directli
use
respiratori
specimen
patient
result
posit
detect
respiratori
specimen
stool
sampl
obtain
time
avail
test
two
rtpcr
assay
perform
use
specimen
posit
detect
one
involv
amplif
fragment
genespecif
primer
sen
antisens
amplifi
variabl
size
fragment
primer
defin
side
highli
acid
domain
sen
antisens
rtpcr
product
sequenc
obtain
nucleotid
sequenc
partial
gene
compar
prototyp
strain
sequenc
avail
genbank
align
prepar
use
clustal
x
version
phylogenet
tree
construct
neighborjoin
method
bootstrap
valu
determin
replic
use
outgroup
medic
record
examin
retrospect
patient
test
result
posit
among
cell
cultur
test
rtpcr
posit
sampl
consist
coronavirus
posit
posit
posit
rhinovirus
enteroviru
influenza
viru
c
codetect
one
consist
influenza
viru
c
consist
rhinoviru
elimin
cell
cultur
contamin
n
gene
rtpcr
perform
directli
respiratori
specimen
obtain
patient
specimen
well
stool
sampl
avail
patient
found
posit
result
amplicon
result
amplif
partial
n
gene
sequenc
specimen
posit
result
genbank
access
number
figur
isol
share
nucleotid
ident
region
refer
strain
sequenc
amplicon
correspond
partial
spike
gene
posit
specimen
genet
sequenc
posit
specimen
could
obtain
primer
use
amplif
partial
spike
gene
amplifi
pcr
product
suffici
quantiti
allow
reliabl
genet
sequenc
analysi
phylogenet
analysi
sequenc
genbank
access
number
show
isol
form
group
contain
sequenc
differ
marker
crosscontamin
differ
isol
three
isol
cluster
prototyp
strain
describ
hong
kong
one
isol
characterist
outlier
figur
determin
isol
contain
variabl
number
tandem
copi
repeat
regionth
signific
featur
sequenc
amplicon
result
rtpcr
region
confirm
number
atr
test
conduct
sever
time
isol
result
show
atr
isol
test
compar
atr
record
hong
kong
isol
detect
nasal
stool
sampl
obtain
patient
male
femal
tabl
age
infect
patient
rang
month
year
except
one
man
patient
age
distribut
patient
infect
age
distribut
test
patient
close
medic
record
patient
examin
three
patient
admit
hospit
sever
dehydr
due
fever
vomit
diarrhea
upper
respiratori
symptom
rhiniti
pharyng
otiti
also
report
unfortun
stool
sampl
patient
avail
hospit
patient
febril
seizur
otiti
respiratori
stool
sampl
test
posit
patient
admit
hospit
complet
investig
suffer
acut
symptom
patient
girl
failur
thrive
patient
man
bruton
agammaglobulinemia
hyperleucocytosi
final
diagnosi
chronic
myeloid
leukaemia
stool
sampl
obtain
patient
avail
test
posit
first
character
hong
kong
januari
respiratori
specimen
adult
pneumonia
previous
unrecogn
group
coronaviru
clinic
signific
viral
infect
made
evid
index
patient
combin
evolut
clinic
symptom
viral
load
respiratori
sampl
develop
specif
antibodi
respons
index
patient
chines
man
poor
underli
condit
pulmonari
tuberculosi
complic
bronchiectasi
histori
chronic
smoker
obstruct
airway
diseas
admit
hospit
pneumonia
discharg
day
hospit
howev
respiratori
stool
urin
sampl
collect
weekli
period
viral
load
respiratori
specimen
decreas
second
week
ill
undetect
third
week
decreas
viral
load
accompani
recoveri
ill
develop
specif
antibodi
respons
detect
respiratori
specimen
stool
urin
sampl
report
date
geograph
tempor
distribut
clinic
symptom
associ
viru
studi
arbitrari
decis
made
screen
cell
cultur
show
cytopath
effect
day
onset
infect
inocul
nasal
specimen
collect
winter
month
februari
march
choic
cell
made
studi
show
cell
appear
broad
spectrum
allow
detect
wide
rang
virus
includ
coronavirus
mhv
unfortun
fail
amplifi
cell
serial
passag
first
passag
could
see
cytopath
effect
day
howev
lack
specif
antibodi
could
test
cell
know
whether
infect
cell
show
viral
replic
rna
detect
rtpcr
may
residu
viru
clinic
sampl
viru
amplifi
cell
cultur
first
passag
cell
durat
incub
limit
day
may
insuffici
growth
coronavirus
experi
conduct
adapt
strain
cell
line
six
patient
infect
includ
children
adult
sampl
obtain
mainli
pediatr
depart
test
patient
children
high
frequenc
figur
phylogenet
analysi
region
partial
spike
gene
human
coronaviru
hcov
isol
franc
phylogenet
tree
construct
neighborjoin
method
bootstrap
valu
determin
replic
clustal
x
version
construct
tree
refer
strain
includ
use
outgroup
studi
suggest
could
also
winter
season
region
better
understand
epidemiolog
differ
hcov
differ
part
world
could
contribut
better
manag
molecular
serolog
diagnosi
futur
emerg
reemerg
virus
sarscov
lack
systemat
select
test
sampl
patient
posit
result
present
case
report
note
onehalf
patient
admit
hospit
respiratori
ill
gastroenter
result
sever
dehydr
associ
upper
respiratori
symptom
effect
previou
studi
suggest
coronavirus
sarscov
may
involv
enter
diseas
despit
fact
clear
evid
caus
enter
ill
would
surpris
view
clear
involv
sarscov
anim
coronaviru
strain
sever
diarrheal
diseas
shown
detect
stool
sampl
nevertheless
studi
must
conduct
confirm
potenti
dual
tropism
respiratori
enter
group
coronaviru
also
detect
patient
without
acut
symptom
poor
underli
condit
patient
although
hcov
except
sarscov
gener
associ
acut
selflimit
respiratori
infect
detect
viral
rna
relat
persist
asymptomat
chronic
infect
chiu
et
al
report
repeat
detect
immunocompromis
child
month
old
genet
analysi
region
spike
protein
region
reveal
specimen
ident
genet
sequenc
provid
evid
viru
persist
rather
reinfect
patient
test
posit
influenza
c
viru
detect
clinic
specimen
possibl
determin
whether
true
coinfect
whether
virus
repres
continu
shed
previou
infect
interest
note
genom
group
coronavirus
influenza
c
viru
contain
gene
phylogenet
analysi
suggest
gene
coronavirus
influenza
c
common
ancestr
origin
hcov
influenza
c
viru
infect
similar
tissu
signific
sequenc
homolog
gene
virus
suggest
coinfect
follow
recombin
could
occur
past
express
gene
shown
heterogen
differ
speci
group
coronavirus
biolog
signific
protein
well
understood
experi
perform
determin
essenti
function
especi
cell
tropism
conclus
report
molecular
method
allow
detect
new
coronaviru
abl
detect
respiratori
sampl
stool
specimen
indic
viru
excret
way
result
indic
present
hospit
patient
mild
respiratori
enter
tract
ill
determin
whether
caus
enter
diseas
requir
investig
phylogenet
analysi
isol
suggest
variant
may
cocircul
first
observ
report
infect
franc
futur
studi
yield
moreaccur
data
circul
viru
